(Q46790729)

English

Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trial

scientific article published in July 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trial (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

multicenter clinical trial

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

K. Rajender Reddy

9

object named as

K Rajender Reddy

1 reference

Europe PubMed Central

25 December 2017

Patrick Marcellin

6

object named as

Patrick Marcellin

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

author name string

Paul J Pockros

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

Robert Carithers

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

Paul Desmond

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

Daniel Dhumeaux

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

Michael W Fried

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

Mitchell L Shiffman

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

Gerald Minuk

8

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

Robert W Reindollar

10

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

Amy Lin

11

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

Michael J Brunda

12

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

PEGASYS International Study Group

13

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

language of work or name

0 references

publication date

1 July 2004

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

99

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

1298-1305

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30306.X

21 January 2018

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30306.X

21 January 2018

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30306.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30306.X

21 January 2018

Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30306.X

21 January 2018

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30306.X

21 January 2018

Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30306.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2004.30306.X

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/15233669

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46790729&oldid=2132227685"